Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
Apply
Anti-GARP CAR T Cell Therapy
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step